HLS Therapeutics (HLS.V) Q1 2025 Earnings

13MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.26
-0.22
-0.17
-0.13

Details

Expected EPS
-0.12751893875
Actual EPS
-0.144293
Surprise EPS
-0.02
Surprise Percent
+13.15%

Description

HLS Therapeutics (HLS.V) has reported earnings of -0.144293 per share for Q1 2025.

0 Comments

Share your thoughts